Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two Antiretroviral Regimens in HIV-Infected Children
NCT00000924Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised trial of didanosine, nelfinavir, ritonavir, stavudine and nevirapine in human immunodeficiency virus infection (HIV) (4 arms), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoint: Plasma HIV-1 RNA concentrations. Status: completed.
02
Drugs
didanosinenelfinavirritonavirstavudinenevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00000924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000924.